← Leaderboards
Peter S Rowe
University Of Texas Hlth Sci Ctr San Ant
$4,213,243
Attributed
$4,797,822
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $591.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,797,822 · 4
By mechanism
R01$4,651,822 · 3
R03$146,000 · 1
Top collaborators
- Jason Stubbs2 shared
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Stephen Eubank Harris$5,126,140
- Jelica Gluhak Heinrich$144,285
Others in their field
Top investigators on “Peptides”
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- John M Lachin · George Washington University$118,672,444
- David Heimbrook · Leidos Biomedical Research, Inc.$91,429,616
- Michael W Weiner · Northern California Institute Res &Educ$78,425,041
- Paul S. Aisen · Cognition Therapeutics, Inc.$69,846,203
- Rolf Apweiler · European Molecular Biology Laboratory$56,677,991
Research focus
PeptidesIn VivoRattusProteinsInorganic PhosphateSerumPlayIn VitroMineralizationPreventChronic Kidney FailureOsteoblastsKidney DiseasesEnd Stage Renal FailureMediatingOsteomalaciaMapsInhibitor/AntagonistKidneyPeptide HydrolasesOsteopontinDefectFamilial Hypophosphatemic Bone DiseaseBone
Grant awards (18)
Preventing vascular calcification in kidney disease$591,857
R01 · FY2025 · HL · contact PI
Preventing vascular calcification in kidney disease$577,302
R01 · FY2024 · HL · contact PI
The Molecular Pathology and Etiology of Nephrogenic Systemic Fibrosis$229,500
R01 · FY2019 · DK · contact PI
The Molecular Pathology and Etiology of Nephrogenic Systemic Fibrosis$229,500
R01 · FY2018 · DK · contact PI
The Molecular Pathology and Etiology of Nephrogenic Systemic Fibrosis$229,500
R01 · FY2017 · DK · contact PI
Mineralization of the matrix in disease and health$304,722
R01 · FY2013 · AR · contact PI
Mineralization of the matrix in disease and health$320,760
R01 · FY2012 · AR · contact PI
Mineralization of the matrix in disease and health$320,760
R01 · FY2011 · AR · contact PI
Mineralization of the matrix in disease and health$334,125
R01 · FY2010 · AR · contact PI
Mineralization of the matrix in disease and health$378,000
R01 · FY2009 · AR · contact PI
Mineralization of the matrix in disease and health$307,533
R01 · FY2007 · AR · contact PI
Mineralization of the matrix in disease and health$315,800
R01 · FY2006 · AR · contact PI
Mineralization of the matrix in disease and health$142,928
R01 · FY2005 · AR
Mineralization of the matrix in disease and health$115,004
R01 · FY2005 · AR
Mineralization and the Role of Matrixphosphoglycoprotein$46,726
R03 · FY2005 · DE
Mineralization and the Role of Matrixphosphoglycoprotein$26,274
R03 · FY2005 · DE
Mineralization of the matrix in disease and health$254,531
R01 · FY2004 · AR
Mineralization and the Role of Matrixphosphoglycoprotein$73,000
R03 · FY2004 · DE